DE69611445T2 - Verfahren zum herstellen von höchstreinem albumin - Google Patents

Verfahren zum herstellen von höchstreinem albumin

Info

Publication number
DE69611445T2
DE69611445T2 DE69611445T DE69611445T DE69611445T2 DE 69611445 T2 DE69611445 T2 DE 69611445T2 DE 69611445 T DE69611445 T DE 69611445T DE 69611445 T DE69611445 T DE 69611445T DE 69611445 T2 DE69611445 T2 DE 69611445T2
Authority
DE
Germany
Prior art keywords
albumin
affinity
chromatography
positive mode
producing high
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69611445T
Other languages
English (en)
Other versions
DE69611445D1 (de
Inventor
Andrew Robert Goodey
Darrell Sleep
Urk Hendrik Van
Stephen Berezenko
John Rodney Woodrow
Richard Alan Johnson
Patricia Carol Wood
Stephen James Burton
Alan Victor Quirk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes Biopharma DK AS
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Publication of DE69611445D1 publication Critical patent/DE69611445D1/de
Application granted granted Critical
Publication of DE69611445T2 publication Critical patent/DE69611445T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
DE69611445T 1995-05-25 1996-02-29 Verfahren zum herstellen von höchstreinem albumin Expired - Lifetime DE69611445T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/378,859 US5728553A (en) 1992-09-23 1995-05-25 High purity albumin and method of producing
PCT/GB1996/000449 WO1996037515A1 (en) 1995-05-25 1996-02-29 Process of high purity albumin production

Publications (2)

Publication Number Publication Date
DE69611445D1 DE69611445D1 (de) 2001-02-08
DE69611445T2 true DE69611445T2 (de) 2001-07-19

Family

ID=23494845

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69632353T Expired - Lifetime DE69632353T2 (de) 1995-05-25 1996-02-29 Hochreines Albumin, durch ein mehrstufiges Verfahren hergestellt
DE69611445T Expired - Lifetime DE69611445T2 (de) 1995-05-25 1996-02-29 Verfahren zum herstellen von höchstreinem albumin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69632353T Expired - Lifetime DE69632353T2 (de) 1995-05-25 1996-02-29 Hochreines Albumin, durch ein mehrstufiges Verfahren hergestellt

Country Status (16)

Country Link
US (6) US5728553A (de)
EP (2) EP1031578B1 (de)
JP (4) JP4040088B2 (de)
KR (2) KR100543612B1 (de)
CN (4) CN1198844C (de)
AT (2) ATE198482T1 (de)
AU (1) AU698409B2 (de)
CA (1) CA2220923C (de)
DE (2) DE69632353T2 (de)
DK (2) DK0828759T3 (de)
ES (2) ES2156991T3 (de)
GR (1) GR3035651T3 (de)
HK (2) HK1009456A1 (de)
MX (1) MX9709108A (de)
PT (2) PT1031578E (de)
WO (1) WO1996037515A1 (de)

Families Citing this family (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
DE19538625C2 (de) * 1995-10-17 1999-08-12 Sartorius Gmbh Verfahren zur Abtrennung von Albumin aus Serum durch Membranionenaustauschchromatographie
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
EP0889949B1 (de) * 1996-03-13 2003-05-28 Delta Biotechnology Limited Gärungs-steuerungssysteme
AU2007200859A1 (en) * 1999-01-30 2007-03-22 Novozymes Delta Limited Process
GB9902000D0 (en) * 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
FR2792650B1 (fr) * 1999-04-20 2003-02-28 Oreal Equivalent de peau agee, son procede de preparation et son utilisation
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US7780967B2 (en) 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
MXPA02007519A (es) * 2000-02-08 2004-10-15 Allergan Inc Composiciones farmaceuticas de toxina botulinica.
US8632785B2 (en) 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
EP1832599A3 (de) * 2000-04-12 2007-11-21 Human Genome Sciences, Inc. Albuminfusionsproteine
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
CN101632669B (zh) 2000-08-04 2011-05-18 Dmi生物科学公司 二酮基哌嗪和包含它们的组合物的使用方法
JP4798833B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法
JP4798832B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
EP1329460B1 (de) * 2000-10-24 2006-06-28 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Verfahren zur monomerisierung von humanen serumalbumin-polymeren
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
US7507413B2 (en) * 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
NZ529767A (en) * 2001-06-13 2005-10-28 Taurus Hsa Llc Purification of human serum albumin
ITBO20010426A1 (it) * 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
JP2003040798A (ja) * 2001-07-26 2003-02-13 Nihon Pharmaceutical Co Ltd 低アルミニウム含有アルブミン製剤およびその製造法
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
AU2002364587A1 (en) 2001-12-21 2003-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
WO2003059884A1 (en) * 2001-12-21 2003-07-24 X-Ceptor Therapeutics, Inc. Modulators of lxr
US20080167238A1 (en) * 2001-12-21 2008-07-10 Human Genome Sciences, Inc. Albumin Fusion Proteins
DK1463751T3 (da) 2001-12-21 2013-08-26 Human Genome Sciences Inc Albuminfusionsproteiner.
US7482366B2 (en) 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
JP4674317B2 (ja) * 2002-10-02 2011-04-20 ディエムアイ アクイジション コーポレイション 疾病の判定および監視
KR20150080004A (ko) 2003-05-15 2015-07-08 앰피오 파마슈티컬스 인코퍼레이티드 Ｔ-세포 매개성 질환의 치료 방법
US8013611B2 (en) * 2006-07-14 2011-09-06 Reserve Power Cell, Llc Vehicle battery product and battery monitoring system
US7339347B2 (en) 2003-08-11 2008-03-04 Reserve Power Cell, Llc Apparatus and method for reliably supplying electrical energy to an electrical system
GB0329722D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
GB0329681D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
KR20070006708A (ko) * 2004-01-07 2007-01-11 트라이머리스 인코퍼레이티드 ＨＩＶ ｇｐ41 ＨＲ2-유래된 합성 펩티드 및 인간 면역결핍바이러스의 전염을 저해하는 치료에서 이들의 용도
JP4644604B2 (ja) 2004-01-20 2011-03-02 一般財団法人化学及血清療法研究所 ２価陽イオン存在下加熱処理によるヒト血清アルブミンの製造方法
US20050244472A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
US20060182783A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
US8591885B2 (en) * 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
DK2330200T3 (en) * 2004-12-23 2017-07-24 Albumedix As GENE EXPRESSION TECHNIQUE
WO2006094185A2 (en) * 2005-03-03 2006-09-08 Dmi Biosciences Inc. Quantification of proteins
US7598700B2 (en) * 2005-03-30 2009-10-06 Reserve Power Cell, Llc Tamper resistant battery and battery warranty and performance tracking system
MY144344A (en) * 2005-04-08 2011-09-15 Ciba Holding Inc Adsorbents comprising anthraquinone dye-ligands for the separation of biological materials
DE102005023155A1 (de) * 2005-05-13 2006-11-16 Albutec Gmbh Albuminlösung
US8323666B2 (en) 2005-08-01 2012-12-04 Allergan, Inc. Botulinum toxin compositions
GB0518460D0 (en) * 2005-09-09 2005-10-19 Univ Nottingham Trent Protein assay
ES2381631T3 (es) 2006-02-02 2012-05-30 Synageva Biopharma Corp. Péptidos inhibidores de la fusión del VIH con propiedades biológicas mejoradas
JP2007284425A (ja) * 2006-03-20 2007-11-01 Nokodai Tlo Kk タンパク質の精製方法
WO2007146038A2 (en) * 2006-06-07 2007-12-21 Human Genome Sciences, Inc. Albumin fusion proteins
KR101507021B1 (ko) * 2006-07-13 2015-03-30 업퍼톤 리미티드 단백질성 물질의 입자를 제조하기 위한 방법
JP5102833B2 (ja) 2006-07-24 2012-12-19 バイオレクシス ファーマシューティカル コーポレーション エキセンディン融合タンパク質
US10829733B2 (en) * 2007-01-04 2020-11-10 Biolamina Ab Composition and method for enabling proliferation of pluripotent human stem cells
BRPI0809995A2 (pt) * 2007-04-03 2015-07-21 Trimeris Inc Composição, e, métodos para a liberação prolongada de um peptídeo em um paciente e para melhorar um sintoma associado com uma infecção por hiv
CN101104635B (zh) * 2007-04-30 2010-11-03 北京济普霖生物技术有限公司 一种从转基因牛乳中纯化重组人α-乳清白蛋白的方法
EP2594583A1 (de) 2007-08-08 2013-05-22 Novozymes Biopharma DK A/S Transferrinvarianten und Konjugate
KR20100080812A (ko) * 2007-09-25 2010-07-12 트라이머리스, 인코퍼레이티드 치료용 항-ｈｉｖ 펩티드의 합성 방법
EP2261661A4 (de) 2008-03-31 2011-04-20 Sekisui Medical Co Ltd Gereinigtes serumalbumin und immunologie-messverfahren
EP2301561A4 (de) * 2008-05-15 2012-02-29 R Tech Ueno Ltd Pharmazeutische zusammensetzung zur behandlung von trockenen augen und/oder hornhaut/bindehaut-erkrankungen
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
US8420051B2 (en) 2008-06-24 2013-04-16 Technische Universitaet Meunchen Muteins of hNGAL and related proteins with affinity for a given target
SG172789A1 (en) 2009-02-11 2011-08-29 Novozymes Biopharma Dk As Albumin variants and conjugates
CN102369276B (zh) * 2009-02-20 2015-02-04 文特里亚生物科学公司 含有蛋白质组合的细胞培养基
DE102009013914B4 (de) * 2009-03-19 2011-05-05 Bruker Daltonik Gmbh Kalibriersubstanzen für Atmosphärendruck-Ionenquellen
CN102549012B (zh) * 2009-05-07 2015-07-01 诺维信生物制药丹麦公司 纯化白蛋白的方法
AU2010280688A1 (en) 2009-08-05 2012-02-23 Allergan, Inc. Controlled release formulations of lipocalin muteins
IN2012DN01849A (de) * 2009-08-20 2015-08-21 Baxter Int
GB2488077A (en) 2009-10-30 2012-08-15 Novozymes Biopharma Dk As Albumin variants
CA2779562C (en) 2009-12-07 2019-12-31 Pieris Ag Muteins of human lipocalin 2 (lcn2, hngal) with affinity for a given target
EP2529006A4 (de) * 2010-01-25 2014-01-08 Ventria Bioscience Verfahren und zusammensetzungen für verbesserte proteinherstellung
JP5969458B2 (ja) 2010-04-09 2016-08-17 アルブミディクス アクティーゼルスカブ アルブミン誘導体及び変異体
DK2580236T3 (da) 2010-06-08 2019-06-11 Pieris Pharmaceuticals Gmbh Muteiner af tåre-lipocalin, der binder til il-4-r-alfa
US9051382B2 (en) 2010-08-16 2015-06-09 Pieris Ag Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such
CA2810844C (en) 2010-09-07 2017-03-21 Dmi Acquisition Corp. Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions
CA2817779C (en) 2010-11-15 2019-02-19 Pieris Ag Muteins of human lipocalin 2 with affinity for glypican-3 (gpc3)
EP2646552B1 (de) 2010-12-02 2017-07-05 Pieris Pharmaceuticals GmbH Muteine von menschlichem lipocalin 2 mit affinität für ctla-4
PL221899B1 (pl) 2011-05-06 2016-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Czysta albumina oraz sposób jej otrzymywania i detekcji
CN103649111B (zh) 2011-07-05 2018-03-13 阿尔布梅迪克斯医疗公司 白蛋白制剂和用途
CA2846464A1 (en) 2011-10-10 2013-04-18 Ampio Pharmaceuticals, Inc. Implantable medical devices with increased immune tolerance, and methods for making and implanting
BR112014007675A2 (pt) 2011-10-10 2017-04-18 Ampio Pharmaceuticals Inc tratamento de doença articular degenerativa
EP2771007B1 (de) 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Behandlung von rhinitis
WO2013075066A2 (en) 2011-11-18 2013-05-23 Eleven Biotherapeutics, Inc. Proteins with improved half-life and other properties
WO2013087660A1 (en) 2011-12-13 2013-06-20 Pieris Ag Methods for preventing or treating certain disorders by inhibiting binding of il-4 and/or il-13 to their respective receptors
DK2825556T3 (en) 2012-03-16 2018-04-16 Albumedix As albumin Variants
WO2013174783A1 (en) 2012-05-23 2013-11-28 Pieris Ag Lipocalin muteins with binding-affinity for glypican-3 (gpc-3) and use of lipocalin muteins for target-specific delivery to cells expressing gpc-3
US20140031527A1 (en) * 2012-07-27 2014-01-30 Csl Limited Method for polishing albumin
KR20150082422A (ko) 2012-11-08 2015-07-15 노보자임스 바이오파마 디케이 에이/에스 알부민 변이체
EP2920202B1 (de) 2012-11-19 2018-08-29 Pieris Pharmaceuticals GmbH Neue spezifisch bindende polypeptide und ihre verwendung
US20140186447A1 (en) * 2012-12-28 2014-07-03 Abraxis Bioscience, Llc Nanoparticle compositions of albumin and paclitaxel
JP6128677B2 (ja) * 2013-02-05 2017-05-17 公立大学法人大阪市立大学 神経細胞の遊走障害を伴う疾患の判定方法及びその利用
CA2905186A1 (en) 2013-03-14 2014-09-18 Daiichi Sankyo Co., Ltd Novel binding proteins for pcsk9
US9808454B2 (en) 2013-03-15 2017-11-07 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CN103694343B (zh) * 2013-12-26 2016-05-25 扬州艾迪生物科技有限公司 一种从尿液中制备人血白蛋白的方法
US10927154B2 (en) 2014-01-13 2021-02-23 Pieris Pharmaceuticals Gmbh Multi-specific polypeptide useful for localized tumor immunomodulation
WO2015166072A1 (en) * 2014-04-30 2015-11-05 Novo Nordisk A/S Methods for the purification of proteins using caprylic acid
EP3789397B1 (de) 2014-05-22 2023-12-06 Pieris Pharmaceuticals GmbH Neuartige polypeptide mit spezifischer bindung und verwendungen davon
AU2015305611B2 (en) 2014-08-18 2020-04-23 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
CN104628830A (zh) * 2015-01-23 2015-05-20 深圳康泰生物制品股份有限公司 重组酿酒酵母表达HBsAg的制备工艺及其分离纯化工艺、HBsAg和乙肝疫苗
EP3250586B1 (de) 2015-01-28 2021-10-27 Pieris Pharmaceuticals GmbH Neuartige angiogenesespezifische proteine
MA41072A1 (fr) 2015-02-18 2018-10-31 Sanofi Sa Nouvelles protéines spécifiques de la pyoverdine et de la pyochéline
US10527604B1 (en) 2015-03-05 2020-01-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
US10705070B1 (en) 2015-03-05 2020-07-07 Abraxis Bioscience, Llc Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
NZ736560A (en) 2015-05-04 2021-12-24 Pieris Pharmaceuticals Gmbh Proteins specific for cd137
US10865250B2 (en) 2015-05-04 2020-12-15 Pieris Pharmaceuticals Gmbh Anti-cancer fusion polypeptide
WO2016184882A1 (en) 2015-05-18 2016-11-24 Pieris Pharmaceuticals Gmbh Anti-cancer fusion polypeptide
CN114456252A (zh) 2015-05-18 2022-05-10 皮里斯制药有限公司 对磷脂酰肌醇聚糖-3（gpc3）具有亲和力的人脂质运载蛋白2的突变蛋白
WO2016209969A1 (en) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
EP3115371A1 (de) 2015-07-07 2017-01-11 Sanofi Fusionsmoleküle
EA201890198A1 (ru) 2015-07-15 2018-07-31 ПИЕРИС ФАРМАСЬЮТИКАЛС ГмбХ Новые белки, специфичные в отношении lag-3
CA2989966A1 (en) 2015-08-20 2017-02-23 Albumedix A/S Albumin variants and conjugates
FR3040882A1 (fr) * 2015-09-10 2017-03-17 Lab Francais Du Fractionnement Composition liquide d'albumine humaine a usage therapeutique
US10703810B2 (en) 2015-11-30 2020-07-07 Pieris Australia Pty Ltd. Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2)
TW201725212A (zh) 2015-12-10 2017-07-16 第一三共股份有限公司 特異性於降鈣素基因相關胜肽的新穎蛋白
CN108431204A (zh) 2015-12-22 2018-08-21 阿尔布梅迪克斯医疗有限公司 改良的表达蛋白质的菌株
KR102050852B1 (ko) * 2016-03-11 2019-12-03 주식회사 스템온 세포 리프로그래밍 장치
EP3500588A1 (de) * 2016-08-17 2019-06-26 Boehringer Ingelheim International GmbH Verfahren zur herstellung von hochkonzentrierten flüssigen formulierungen mit biomolekülen
DK3429345T3 (da) 2016-10-04 2019-11-25 Albumedix Ltd Anvendelser af rekombinant gær-afledt serumalbumin
WO2018087108A1 (en) 2016-11-09 2018-05-17 Pieris Pharmaceuticals Gmbh Proteins specific for cd137
RU2019122482A (ru) 2017-01-18 2021-02-19 Пирис Фармасьютикалс Гмбх Мутеины липокалина с аффинностью связывания в отношении lag-3
WO2018165766A1 (en) * 2017-03-16 2018-09-20 Therapure Biopharma Inc. Method for purification of albumin
WO2018234349A1 (en) 2017-06-20 2018-12-27 Albumedix Ltd IMPROVED STRAINS FOR THE EXPRESSION OF PROTEINS
CN110563833A (zh) * 2018-06-06 2019-12-13 中国计量科学研究院 一种人血白蛋白标准物质原料的制备方法及其产品和应用
PL3830120T3 (pl) 2018-07-31 2023-10-09 Pieris Pharmaceuticals Gmbh NOWE BIAŁKO FUZYJNE SWOISTE WOBEC CD137 i PD-L1
CN109734796B (zh) * 2019-02-01 2022-04-15 广州蕊特生物科技有限公司 一种从溶血血清中分离白蛋白的工艺
CN109776673B (zh) * 2019-02-20 2022-03-29 天津理工大学 一种适合中试量产的高纯度牛血清白蛋白纯化工艺
MA55069A (fr) 2019-02-26 2022-01-05 Pieris Pharmaceuticals Gmbh Nouvelles protéines de fusion spécifique à cd137 et gpc3
CN110229229A (zh) * 2019-07-10 2019-09-13 甘肃养泰和生物科技有限公司 一种从牛血浆中提取纯化细胞培养级牛血清白蛋白的生产方法及其应用
US11497737B2 (en) 2019-10-28 2022-11-15 Abraxis Bioscience, Llc Pharmaceutical compositions of albumin and rapamycin
JP2023527908A (ja) 2020-06-05 2023-06-30 ピエリス ファーマシューティカルズ ゲーエムベーハー ４－１ｂｂをターゲティングする多量体免疫調節物質
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
KR20230060524A (ko) 2020-12-08 2023-05-04 통화 안레이트 바이오파마슈티컬 컴퍼니 리미티드 재조합 단백질의 정제 방법
EP4320141A1 (de) 2021-04-08 2024-02-14 Pieris Pharmaceuticals GmbH Neue für den bindegewebewachstumsfaktor (ctgf) spezifische lipocalinmuteine
WO2022243341A1 (en) 2021-05-18 2022-11-24 Pieris Pharmaceuticals Gmbh Lipocalin muteins with binding affinity for ox40
CN113735963A (zh) * 2021-09-10 2021-12-03 山东健通生物科技有限公司 一种重组人血清白蛋白纯化过程去除色素的方法
CN114316088B (zh) * 2021-12-22 2022-09-09 中国水产科学研究院黄海水产研究所 亲和树脂、制备方法及其在分离纯化藻蓝蛋白中的应用
WO2024064713A1 (en) 2022-09-21 2024-03-28 Seagen Inc. Novel fusion protein specific for cd137 and cd228
CN116120392B (zh) * 2023-04-18 2023-08-01 上海健士拜生物科技有限公司 聚体蛋白的纯化方法

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019919D0 (en) * 1990-09-12 1990-10-24 Delta Biotechnology Ltd Purification of proteins
US2433905A (en) 1943-11-01 1948-01-06 Jr Walter L Hughes Method for the crystallization of albumin and the preparation of protein products therefrom
AT317418B (de) * 1972-06-16 1974-08-25 Brigitte Panhofer Verfahren zur Herstellung von intravenös beim Menschen anwendbarem Humanalbumin aus menschlichen Placenten
FR2190437B1 (de) 1972-07-05 1975-08-08 Merieux Inst
CA1044537A (en) 1973-05-09 1978-12-19 Amf Incorporated Filter medium and process
DE2537123A1 (de) * 1975-08-20 1977-03-03 New Zealand Inventions Dev Verfahren zur herstellung von albumin
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
US4043997A (en) * 1976-05-28 1977-08-23 Cutter Laboratories, Inc. Method for isolating albumin using insoluble supports coupled to a dye
US4075197A (en) * 1976-09-20 1978-02-21 Monsanto Company Serum albumin production
IN150740B (de) 1978-11-24 1982-12-04 Hoffmann La Roche
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
US4222934A (en) * 1979-04-12 1980-09-16 American National Red Cross Preparation of albumin using ethanol
GB2053926B (en) 1979-07-20 1983-02-23 Atkinson A Albumin extraction by affinity chromatography
US4350156A (en) * 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
IL66614A (en) * 1981-08-28 1985-09-29 Genentech Inc Method of constructing a dna sequence encoding a polypeptide,microbial production of human serum albumin,and pharmaceutical compositions comprising it
US4391801A (en) 1981-10-29 1983-07-05 Cutter Laboratories, Inc. Plasma protein fraction substantially free of acetate ions
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
DE3344656A1 (de) * 1983-12-09 1985-06-13 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung einer serumproteinloesung
CA1286622C (en) * 1986-04-28 1991-07-23 Chokyun Rha Method for clarifying and stabilizing cell culture media
JPS62294621A (ja) 1986-06-13 1987-12-22 Green Cross Corp:The アルブミンの回収方法
JPS6383100A (ja) * 1986-09-26 1988-04-13 Green Cross Corp:The ヒト尿中アルブミンの製造方法
US4833233A (en) * 1987-08-20 1989-05-23 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Human serum albumin crystals and method of preparation
IL88326A (en) 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
US4990447A (en) * 1988-06-24 1991-02-05 Gist-Brocades Nv Process for the purification of serum albumin
FR2649991B2 (fr) 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
GB8913586D0 (en) 1989-06-13 1989-08-02 Technicol Limited A method of determining the glycosylated protein level of a sample and an apparatus for use in the method
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
SE500110C2 (sv) 1989-06-27 1994-04-18 Kabi Pharmacia Ab Sätt att rena ett protein från därtill bundna flervärda metalljoner
JPH0671434B2 (ja) 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
CA2022165C (en) 1989-10-05 1999-11-23 Chong E. Chang Albumin purification
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
ES2224094T3 (es) * 1990-04-19 2005-03-01 Bayer Corporation Procedimiento para preparar seroalbumina normal (humana) esencialmente monomerica.
JP3230091B2 (ja) * 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
JP2982296B2 (ja) 1990-11-19 1999-11-22 吉富製薬株式会社 アルブミン含有水溶液の精製法
JP2949846B2 (ja) 1990-11-30 1999-09-20 吉富製薬株式会社 アルブミン製剤の保存方法
FR2672604B1 (fr) * 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
US5284777A (en) 1991-03-04 1994-02-08 Isolab, Inc. Combined glycated hemoglobin and immunoturbidometric glycated albumin assay from whole blood lysate
US5330901A (en) * 1991-04-26 1994-07-19 Research Corporation Technologies, Inc. Expression of human serum albumin in Pichia pastoris
EP0933083A1 (de) * 1991-07-12 1999-08-04 Dsm N.V. Verfahren zur Reinigung von Serumalbumin
FR2686620B1 (fr) * 1992-01-27 1995-06-23 Rhone Poulenc Rorer Sa Serum-albumine humaine, preparation et utilisation.
US5281582A (en) * 1992-02-27 1994-01-25 Alliance Pharmaceuticals, Corp. Serum growth factor
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JP3360315B2 (ja) * 1992-07-31 2002-12-24 三菱ウェルファーマ株式会社 ヒト血清アルブミンの高度精製方法
DE4244915C2 (de) 1992-08-14 1998-12-03 Widmar Prof Dr Tanner DNA-Moleküle codierend Proteine, die an der O-Glykosylierung von Proteinen beteiligt sind
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
CN1055095C (zh) * 1992-12-11 2000-08-02 上海莱士血制品有限公司 白蛋白的纯化方法
CA2116385A1 (en) * 1993-02-25 1994-08-26 Akinori Sumi Human serum albumin and process for producing the same
SE9301583D0 (sv) 1993-05-07 1993-05-07 Kabi Pharmacia Ab Yeast strain and methods for expressing heterologous proteins in yeast
JP3702474B2 (ja) * 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
ES2211889T3 (es) * 1994-08-31 2004-07-16 Mitsubishi Pharma Corporation Procedimiento para la purificacion de albumina de suero recombinante.
JPH09209303A (ja) 1996-02-05 1997-08-12 Hokkaido Supuritsuton Kogyo Kk 舗装ブロック
WO1997031947A1 (en) 1996-02-29 1997-09-04 Delta Biotechnology Limited High purity albumin production process

Also Published As

Publication number Publication date
JP2003048900A (ja) 2003-02-21
DE69632353D1 (de) 2004-06-03
HK1009456A1 (en) 1999-06-04
KR100543612B1 (ko) 2006-01-20
HK1072436A1 (en) 2005-08-26
US20030187226A1 (en) 2003-10-02
EP1031578B1 (de) 2004-04-28
CN1198844C (zh) 2005-04-27
ATE265469T1 (de) 2004-05-15
DE69611445D1 (de) 2001-02-08
CN100443499C (zh) 2008-12-17
EP0828759A1 (de) 1998-03-18
JP4372813B2 (ja) 2009-11-25
CN100584857C (zh) 2010-01-27
US6638740B1 (en) 2003-10-28
ES2219257T3 (es) 2004-12-01
US5728553A (en) 1998-03-17
JP2008037867A (ja) 2008-02-21
JP4040088B2 (ja) 2008-01-30
US20080009042A1 (en) 2008-01-10
JP4372772B2 (ja) 2009-11-25
US20050142636A1 (en) 2005-06-30
CA2220923A1 (en) 1996-11-28
DE69632353T2 (de) 2005-05-04
CN1191545A (zh) 1998-08-26
PT1031578E (pt) 2004-08-31
KR100566606B1 (ko) 2006-12-01
US6034221A (en) 2000-03-07
EP0828759B1 (de) 2001-01-03
CN1880334A (zh) 2006-12-20
MX9709108A (es) 1998-06-30
CN100455597C (zh) 2009-01-28
EP1031578A3 (de) 2001-01-17
GR3035651T3 (en) 2001-06-29
EP1031578A2 (de) 2000-08-30
WO1996037515A1 (en) 1996-11-28
PT828759E (pt) 2001-05-31
ATE198482T1 (de) 2001-01-15
JP2006342169A (ja) 2006-12-21
DK1031578T3 (da) 2004-06-01
ES2156991T3 (es) 2001-08-01
KR20040077917A (ko) 2004-09-07
CN1550504A (zh) 2004-12-01
AU698409B2 (en) 1998-10-29
CA2220923C (en) 2003-01-07
DK0828759T3 (da) 2001-02-26
KR19990021994A (ko) 1999-03-25
AU4838096A (en) 1996-12-11
US7601515B2 (en) 2009-10-13
JP4037174B2 (ja) 2008-01-23
CN1611513A (zh) 2005-05-04
US7223561B2 (en) 2007-05-29

Similar Documents

Publication Publication Date Title
DE69611445D1 (de) Verfahren zum herstellen von höchstreinem albumin
CA2183888A1 (en) Antibody purification
CA2265935A1 (en) Heat shock protein complexes
DE69919701D1 (de) Abtrennung von antikörper-monomeren von deren multimeren mittels ionaustausch-chromatographie
EP0576294A3 (en) Chondroitinase, process for preparing the same, and pharmaceutical composition comprising the same
DE69638291D1 (de) Verfahren zur Reinigung von Faktor IX
AU7067287A (en) Method and apparatus for separating proteins
AU4764385A (en) Method for silver staining proteins and nucleic acids
Fridriksson et al. Electrospray mass spectra from protein electroeluted from sodium dodecylsulfate polyacrylamide gel electrophoresis gels
DE3853224D1 (de) Produktion von Proteinen in aktiver Form.
CA2223702A1 (en) Therapeutic fragments of von willebrand factor
ATE272072T1 (de) Verfahren zur reinigung von menschlichem interleukin-1 rezeptor antagonist aus rekombinanten e.coli
AU6092498A (en) Recombinant fusion proteins based on ribosome-inactivating proteins of european mistletoe (viscum album)
ES2193349T3 (es) Metodo para la produccion de rdspa alfa1.
RU95112503A (ru) Способ выделения предварительно отобранного гемоглобина и очищенный препарат гемоглобина
DE59813491D1 (de) Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats
CA2243578A1 (en) High affinity nucleic acid ligands of complement system proteins
GB8817083D0 (en) Improved method of ion exchange & apparatus for carrying out said method
SU1187866A1 (ru) Способ получени сорбента дл ионной хроматографии
ATE150002T1 (de) Elektrodialytisches verfahren zur trennung von basischen, sauren und amphoteren aminosäuren
JPS57147056A (en) Method for analysis of amino acid
KR940003567A (ko) 면역글로불린 a 및 m이 제거된 정맥주사용 감마글로불린제의 제조방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NOVOZYMES DELTA LTD., NOTTINGHAM, GB

8327 Change in the person/name/address of the patent owner

Owner name: NOVOZYMES BIOPHARMA UK LIMITED, NOTTINGHAM, GB

8327 Change in the person/name/address of the patent owner

Owner name: NOVOZYMES BIOPHARMA DK A/S, BAGSVAERD, DK